Ben Wijnen has won the prize for best article from the Dutch Society of Technology Assessment in Health Care (NVTAG) for his methodological article entitled “A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy” published in the European Journal of Health Economics, 19(6), 861-870.
In this study it was examined whether it is possible to translate disease-specific quality of life (QOLIE-31P) measures into generic quality of life (EQ-5D-5L) measures using different mapping functions. To this end, the study combined the data from two comparable RCTs into the cost-effectiveness of self-management in epilepsy in order to obtain a larger sample (one RCT performed in England and the other in the Netherlands). Mapping proved to be a difficult exercise, as the EQ-5D-5L has limited responsiveness in this population. This methodological exercise therefore reveals that there is a huge need for the development of alternative instruments or additional recommendations in the guideline for economic evaluations with regard to the primary outcome measure in which the EQ-5D-5L is predominant.
This paper is the product of the cooperation between Maastricht University, Care and Public Health Research Institute (Caphri), Trimbos Institute Utrecht, and Kings College London. The yearly award of the Dutch Society of Technology Assessment in Health Care (NVTAG) is granted for the best article in the field of Health Technology Assessment published in 2017 and is a joined decision by a jury and colleagues present during the symposium of the NVTAG. The prize won by several illustrious predecessors, established in 1999, consists of 1000 euros provided by Pharmerit and of course eternal fame.